MARKET

LMAT

LMAT

LeMaitre
NASDAQ

Real-time Quotes | Nasdaq Last Sale

58.15
+0.67
+1.17%
Closed 17:47 09/16 EDT
OPEN
58.38
PREV CLOSE
57.48
HIGH
59.37
LOW
57.91
VOLUME
126.70K
TURNOVER
--
52 WEEK HIGH
64.50
52 WEEK LOW
31.21
MARKET CAP
1.26B
P/E (TTM)
41.88
1D
5D
1M
3M
1Y
5Y
Jefferies Initiates Coverage On LeMaitre Vascular with Buy Rating, Announces Price Target of $70
Jefferies analyst Anthony Petrone initiates coverage on LeMaitre Vascular (NASDAQ:LMAT) with a Buy rating and announces Price Target of $70.
Benzinga · 22h ago
UPDATE: LeMaitre Vascular Says Also Entered Into An Amendment To A Transition Services Agreement With Admedus, Says Amendment Extends Term Of Agreement By 9 Months To July 11, 2023
-Reuters
Reuters · 09/01 20:47
UPDATE: LeMaitre Vascular Says Costs Of Obtaining CE Mark Approvals Will Also Be Assumed By Co., Says Costs Will Be Deducted From $2M Earn-Out Associated With CE Mark Approvals
-Reuters
Reuters · 09/01 20:46
UPDATE: LeMaitre Vascular Says Will Assume Responsibility For Filing For Regulatory Approvals For Products Under European Union Medical Device Regulation
-Reuters
Reuters · 09/01 20:44
LeMaitre Vascular Says On Aug. 28, Amended Agreement Co. Previously Entered Into, On Oct. 11, 2019 With Admedus, Certain Of Units
-Reuters
Reuters · 09/01 20:44
LeMaitre Vascular to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September. Barrington Research 14th Annual Virtual Fall Investment Con...
GlobeNewswire · 09/01 19:21
Is ProShares Russell 2000 Dividend Growers ETF (SMDV) a Strong ETF Right Now?
Zacks.com · 08/24 10:20
LeMaitre to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August.
GlobeNewswire · 08/06 15:07
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LMAT. Analyze the recent business situations of LeMaitre through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LMAT stock price target is 66.14 with a high estimate of 76.00 and a low estimate of 58.00.
EPS
Institutional Holdings
Institutions: 244
Institutional Holdings: 19.68M
% Owned: 90.86%
Shares Outstanding: 21.66M
TypeInstitutionsShares
Increased
68
753.53K
New
25
391.62K
Decreased
58
1.00M
Sold Out
21
266.16K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.49%
Healthcare Equipment & Supplies
-0.15%
Key Executives
President/Director
David Roberts
Chief Financial Officer/Director
Joseph Pellegrino
Senior Vice President/General Counsel
Laurie Churchill
Senior Vice President
Andrew Hodgkinson
Senior Vice President
Trent Kamke
Senior Vice President
Stephane Maier
Vice President/Director of Sales
Giovannella Deiure
Vice President/Director of Sales
Chance Kriesel
Vice President/Director of Marketing
Kimberly Cieslak
Vice President
Roli Kumar-Choudhury
Vice President
Jonathan Ngau
Vice President
Jacob Petersen
Vice President
James Russell
Vice President
Xiang Zhang
Vice President - Research & Development
Ryan Connelly
Director of Sales
Helen Goulding
Director of Sales
Ina Leininger
Director of Human Resources
Daniel Mumford
Other
Christopher Minnett
Independent Director
Lawrence Jasinski
Independent Director
John O'Connor
Independent Director
Bridget Ross
Independent Director
John Roush
Declaration Date
Dividend Per Share
Ex-Div Date
04/27/2021
Dividend USD 0.11
05/18/2021
02/23/2021
Dividend USD 0.11
03/08/2021
10/20/2020
Dividend USD 0.095
11/18/2020
07/21/2020
Dividend USD 0.095
08/26/2020
04/28/2020
Dividend USD 0.095
05/19/2020
01/30/2020
Dividend USD 0.095
03/02/2020
10/21/2019
Dividend USD 0.085
11/19/2019
07/22/2019
Dividend USD 0.085
08/20/2019
04/29/2019
Dividend USD 0.085
05/21/2019
02/14/2019
Dividend USD 0.085
03/21/2019
10/04/2018
Dividend USD 0.07
11/19/2018
07/23/2018
Dividend USD 0.07
08/21/2018
04/23/2018
Dividend USD 0.07
05/21/2018
02/15/2018
Dividend USD 0.07
03/21/2018
10/24/2017
Dividend USD 0.055
11/21/2017
07/25/2017
Dividend USD 0.055
08/21/2017
04/24/2017
Dividend USD 0.055
05/22/2017
02/16/2017
Dividend USD 0.055
03/20/2017
10/24/2016
Dividend USD 0.045
11/17/2016
07/25/2016
Dividend USD 0.045
08/18/2016
About LMAT
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Webull offers kinds of LeMaitre Vascular Inc stock information, including NASDAQ:LMAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMAT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMAT stock methods without spending real money on the virtual paper trading platform.